Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study
Authors
Muhammad Abdul‐Ghani (ORCID: https://orcid.org/0000-0003-4556-1787)
Aurora Merovci
Curtiss Puckett
Siham Abdelgani
Olga Lavrynenko (ORCID: https://orcid.org/0000-0002-2102-2503)
Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study
Muhammad Abdul‐Ghani, Aurora Merovci, Curtiss Puckett, Siham Abdelgani et al.
Citations
2 citations
Journal
BMJ Open Diabetes Research & Care
Topics
Liver Disease Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
2.71
article
Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study
Muhammad Abdul‐Ghani, Aurora Merovci, Curtiss Puckett, Siham Abdelgani, Olga Lavrynenko, Curtis Triplitt, John M. Adams, Ralph A. DeFronzo